Navigation Links
Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol
Date:12/19/2013

t. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release related to our product candidates is preliminary and investigative. Such product candidates are not approved by the U.S. Food and Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates.

CONTACT: Amgen
Ashleigh Koss: 805-313-6151 (media)
Arvind Sood'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amgen Announces 2014 First Quarter Dividend
2. Amgen To Present At The Oppenheimer 24th Annual Healthcare Conference
3. Amgen To Webcast Investor Meeting At Upcoming American Heart Association Scientific Sessions 2013
4. Amgens Third Quarter 2013 Revenues Increased 10 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 16 Percent To $1.94
5. Amgen Acquires Filgrastim Franchise Rights From Roche In 100 Markets
6. Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
7. Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Onyx
8. Amgen And Cytokinetics Announce The First Presentation Of Data From Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil
9. Amgen To Participate At Citis 8th Annual Biotech Conference
10. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
11. Amgen to Highlight New Data at Upcoming ESC Congress 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... March 3, 2015   ... 240 patients respectively Publications in peer reviewed ... Clinical Gastroenterology highlight diagnostic value of confocal laser ... China and across Asia ... (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal ...
(Date:3/3/2015)... March 3, 2015  American Biosurgical, LLC ("ABI") ... cable manufacturer actively engaged in the design, development ... the world,s leading medical device companies has announced ... low volume custom medical cable manufacturer based in ... MTI brand under the name MTI Medical Cables.  ...
(Date:3/3/2015)... BOSTON , March 3, 2015  Columbia Laboratories, ... " or "the Company"), a specialty pharmaceutical company ... it will present at the 27th Annual ROTH Conference, ... Ritz-Carlton Laguna Niguel in Dana Point, California ... March 11 at 9:00 a.m. Pacific Time (12:00 p.m. ...
Breaking Medicine Technology:Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 3Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 4American Biosurgical Acquires MTI Corporation 2
... America, Inc., a global leader in medical diagnostic ... its selection to Center for Companies That Care,s ... of Human Resources, Sysmex America.  As a 2012 ... its outstanding workplace practices and active community involvement.  ...
... 16, 2012  Sanofi (EURONEXT: SAN and NYSE: ... have entered into a definitive agreement under which Sanofi ... based in Woburn, Massachusetts.  The acquisition is subject to ... ) Pluromed has developed a proprietary ...
Cached Medicine Technology:Sysmex America Earns 4th Consecutive Placement on Companies That Care Honor Roll 2Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery 2Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery 3Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery 4
(Date:3/3/2015)... New York, NY (PRWEB) March 03, 2015 ... sleepy this spring. Sanjeev Kothare, MD, has tips for parents. ... tired come March 8 at 2:00 a.m. when they set ... because when you wake up that day -- one hour ... sleep. , That’s why parents should start thinking about “sleep ...
(Date:3/3/2015)... 03, 2015 Sunday, March 1, through Saturday, ... the time of year, every region of the country is ... why Amica Insurance is sharing the following tips ... to help keep you safe in the event of severe ... Change wet clothing frequently to prevent loss of body heat. ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 -- vRad ( Virtual ... practice, today announced that Arlene Sussman, MD, a highly ... a live webinar to explore how telemedicine best practices ... imaging services for women virtually anywhere. Click here ... Service Line” on March 4, 2015 at 1:00 pm ...
(Date:3/3/2015)... Splashtop Inc. , the worldwide leader ... available for Epson® MoverioTM BT-200 smart glasses. ... Market , iPod, iPhone, and iPad users can now ... Moverio smart glasses using Mirroring360, enhancing the user experience ... Epson smart glasses have an advanced binocular optical system ...
(Date:3/3/2015)... March 03, 2015 According to ... http://www.idataresearch.com ), market saturation has made neurosurgery navigation ... the United States. Unit sales growth moderately increased ... as facilities replace older systems, and as new ... market is very much a replacement and upgrade ...
Breaking Medicine News(10 mins):Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:Amica Insurance Has Tips for National Severe Weather Preparedness Week 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 3Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 4Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 2Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 3Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 2Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 3
... Adds Depth to Management Team, BIRMINGHAM, Ala., ... a leader in enterprise medical information technology,systems for ... Chris,E. Perkins has been named Chief Operating Officer. ... at Per-Se Technologies,where he served in senior executive ...
... procedure to be held Thursday, January 17, at ... 3:00 p.m. ... Inc.,(Nasdaq: CRDC ) today announced that leading cardiac surgeons from ... a live off-pump coronary artery bypass graft (CABG) procedure as,well as ...
... children facing their own altered reality, experts say , , MONDAY, ... them of the life they once knew, some people can ... cases -- as highlighted by recent news on retired Supreme ... of the Alzheimer,s patient grows to understand and accept the ...
... --,HearAtLast Holdings, Inc. is proud to announce that it ... WMT ) to open its 16th hearing-aid,clinic to be ... Linden,Dr. in Richmond Hill, Ontario. The new clinic officially ... expansion is a direct result of,the Company exercising its ...
... From One Proxy Advisory Firm, MONTVALE, N.J., ... today issued a statement strongly recommending shareholders,re-elect Datascope,s ... William,L. Asmundson - and reject Ramius Capital,s opposition ... Annual Meeting of Shareholders., Robert Klatell, Chairman ...
... new study finds significant underuse of colorectal cancer screening ... January 15, 2008 issue of CANCER, a peer-reviewed journal ... percent of Medicare patients received recommended screening during the ... leading cause of cancer death in both men and ...
Cached Medicine News:Health News:Emageon Names Chris E. Perkins as Chief Operating Officer 2Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 2Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 3Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 4Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 5Health News: Love in the World of Alzheimer's 2Health News: Love in the World of Alzheimer's 3Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 2Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 3Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 4Health News:Datascope Recommends Shareholders Re-Elect its Two Incumbent Directors and Reject Ramius' Opposition Slate 2Health News:Datascope Recommends Shareholders Re-Elect its Two Incumbent Directors and Reject Ramius' Opposition Slate 3Health News:Datascope Recommends Shareholders Re-Elect its Two Incumbent Directors and Reject Ramius' Opposition Slate 4Health News:Datascope Recommends Shareholders Re-Elect its Two Incumbent Directors and Reject Ramius' Opposition Slate 5Health News:Many Medicare beneficiaries not receiving colorectal cancer screening 2
... design of the LONGLIFE P-O-C ... modern configuration, now with a ... complement any office decor. The ... integrate into existing practices, offering ...
The Onar®Lp -QP test system is an in vitro test for the quantitative diagnosis of legionella in clinical samples....
The VPAP III is a complete system solution for sleep-disordered breathing (SDB), providing comfortable and effective bilevel treatment. The VPAP III is an effective business solution for clinicians, ...
... Polyacrylamide gel Electrophoresis Method for the ... all Lipoprotein Fractions and Subfractions, ,The ... diagnostic test for cholesterol components which ... methods. The Lipoprint test provides detailed ...
Medicine Products: